Insights

Innovative Neuromodulation Spinal Modulation specializes in advanced spinal cord stimulation targeting the dorsal root ganglion, offering a differentiated solution for chronic pain management that can appeal to pain clinics and neurology centers seeking cutting-edge therapies.

Global Market Presence With approvals across Europe and Australia and the recent US pivotal trial, there are expanding international sales opportunities to introduce the Axium Neurostimulator System to new markets with increasing demand for implantable pain relief devices.

Strong Investment Background Supported by notable investors and acquired by St. Jude Medical for $175 million, the company has a solid financial backing, indicating potential for product development and expansion into new territories or complementary pain management solutions.

Regulatory & Clinical Milestones The company's ongoing US clinical trial (ACCURATE Study) positions it for potential FDA approval and broader adoption, creating opportunities to target healthcare providers specializing in nerve injury and complex regional pain syndromes.

Emerging Market Niche Operating with a relatively small revenue base but significant funding, Spinal Modulation presents opportunities to penetrate specialized pain centers and neurology practices that focus on minimally invasive, targeted neuromodulation therapies.

Similar companies to Spinal Modulation (Acquired by St. Jude Medical)

Spinal Modulation (Acquired by St. Jude Medical) Tech Stack

Spinal Modulation (Acquired by St. Jude Medical)'s Email Address Formats

Spinal Modulation (Acquired by St. Jude Medical) uses at least 1 format(s):
Spinal Modulation (Acquired by St. Jude Medical) Email FormatsExamplePercentage
First@spinalmodulation.comJohn@spinalmodulation.com
66%
Last@spinalmodulation.comDoe@spinalmodulation.com
17%
FLast@spinalmodulation.comJDoe@spinalmodulation.com
14%
First.Last@spinalmodulation.comJohn.Doe@spinalmodulation.com
3%

Frequently Asked Questions

Where is Spinal Modulation (Acquired by St. Jude Medical)'s headquarters located?

Minus sign iconPlus sign icon
Spinal Modulation (Acquired by St. Jude Medical)'s main headquarters is located at 1135 O'brien Drive Menlo Park, California 94025 United States. The company has employees across 1 continents, including North America.

What is Spinal Modulation (Acquired by St. Jude Medical)'s phone number?

Minus sign iconPlus sign icon
You can contact Spinal Modulation (Acquired by St. Jude Medical)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Spinal Modulation (Acquired by St. Jude Medical)'s official website and social media links?

Minus sign iconPlus sign icon
Spinal Modulation (Acquired by St. Jude Medical)'s official website is spinalmodulation.com and has social profiles on LinkedIn.

What is Spinal Modulation (Acquired by St. Jude Medical)'s NAICS code?

Minus sign iconPlus sign icon
Spinal Modulation (Acquired by St. Jude Medical)'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Spinal Modulation (Acquired by St. Jude Medical) have currently?

Minus sign iconPlus sign icon
As of December 2025, Spinal Modulation (Acquired by St. Jude Medical) has approximately 51 employees across 1 continents, including North America. Key team members include Ceo: A. B.Vice President Mechanical R And D: A. B.Vice President Engineering And Operat: R. O.. Explore Spinal Modulation (Acquired by St. Jude Medical)'s employee directory with LeadIQ.

What industry does Spinal Modulation (Acquired by St. Jude Medical) belong to?

Minus sign iconPlus sign icon
Spinal Modulation (Acquired by St. Jude Medical) operates in the Medical Equipment Manufacturing industry.

What is Spinal Modulation (Acquired by St. Jude Medical)'s email format?

Minus sign iconPlus sign icon
Spinal Modulation (Acquired by St. Jude Medical)'s email format typically follows the pattern of First@spinalmodulation.com. Find more Spinal Modulation (Acquired by St. Jude Medical) email formats with LeadIQ.

How much funding has Spinal Modulation (Acquired by St. Jude Medical) raised to date?

Minus sign iconPlus sign icon
As of December 2025, Spinal Modulation (Acquired by St. Jude Medical) has raised $45M in funding. The last funding round occurred on Jun 07, 2013 for $45M.

When was Spinal Modulation (Acquired by St. Jude Medical) founded?

Minus sign iconPlus sign icon
Spinal Modulation (Acquired by St. Jude Medical) was founded in 2004.

Spinal Modulation (Acquired by St. Jude Medical)

Medical Equipment ManufacturingCalifornia, United States51-200 Employees

FOCUS YOUR THERAPY. BROADEN YOUR POSSIBILITIES.

Spinal Modulation is dedicated to improving the lives of patients with chronic pain by providing the next generation of neuromodulation systems through targeted spinal cord stimulation (SCS) of the dorsal root ganglion (DRG). Spinal Modulation is a global medical device company based in Menlo Park, California, Belgium, & Australia. The company is funded by St, Jude Medical, Johnson & Johnson Dev Corp, Medtronic, Kleiner Perkins Caufield & Byers, De Novo Ventures, MedVenture Assoc, InCube Ventures, ePlanet Ventures, Raffles Venture Partners, The Angels Forum & The Halo Fund. St. Jude Medical has the exclusive option to acquire the company following the achievement of certain milestones and is the exclusive distributor of the Axium® Neurostimulator System in international markets where it is approved for sale.

AXIUM® NEUROSTIMULATOR SYSTEM
The Axium Neurostimulator System is a form of SCS that targets a neural structure within the spine called the dorsal root ganglion. The DRG contains the primary sensory neurons that transmit pain signals from the peripheral nerves to the brain. The system uses an implantable medical device to deliver mild electrical pulses to the DRG. These pulses mask or interrupt pain signals as they travel to the brain.

AROUND THE GLOBE
The Axium SCS System has both CE Mark & TGA approval and is helping patients at  pain centers around the world, including Europe & Australia. Over 800 patients have been treated worldwide with the 1st implant performed in 2011.

IN THE UNITED STATES
The ACCURATE Study is a prospective, randomized, multi-center, controlled study to evaluate the safety & efficacy of the Axium Neurostimulator System for the treatment of chronic pain affecting the lower limbs. It is the largest U.S. pivotal trial to evaluate spinal cord stimulation therapy in patients with lower limb pain due to nerve injuries (peripheral causalgia) or complex regional pain syndrome (CRPS).

Section iconCompany Overview

Headquarters
1135 O'brien Drive Menlo Park, California 94025 United States
Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2004
Employees
51-200

Section iconFunding & Financials

  • $45M

    Spinal Modulation (Acquired by St. Jude Medical) has raised a total of $45M of funding over 5 rounds. Their latest funding round was raised on Jun 07, 2013 in the amount of $45M.

  • $1M$10M

    Spinal Modulation (Acquired by St. Jude Medical)'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $45M

    Spinal Modulation (Acquired by St. Jude Medical) has raised a total of $45M of funding over 5 rounds. Their latest funding round was raised on Jun 07, 2013 in the amount of $45M.

  • $1M$10M

    Spinal Modulation (Acquired by St. Jude Medical)'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.